We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 7/19/2013
Updated: 7/19/2013
A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 7/19/2013
Updated: 7/19/2013
Click here to add this to my saved trials
Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
Updated: 7/22/2013
A Pilot, Single-Masked Study to Compare the Safety and Efficacy of ALZ-1101 (Latanoprost 0.005%/Dorzolamide 2.0%) to Latanoprost Ophthalmic Solution, 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension With Intraocular Pressure Inadequately Controlled By Latanoprost
Status: Enrolling
Updated: 7/22/2013
Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
Updated: 7/22/2013
A Pilot, Single-Masked Study to Compare the Safety and Efficacy of ALZ-1101 (Latanoprost 0.005%/Dorzolamide 2.0%) to Latanoprost Ophthalmic Solution, 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension With Intraocular Pressure Inadequately Controlled By Latanoprost
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
Updated: 7/22/2013
A Pilot, Single-Masked Study to Compare the Safety and Efficacy of ALZ-1101 (Latanoprost 0.005%/Dorzolamide 2.0%) to Latanoprost Ophthalmic Solution, 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension With Intraocular Pressure Inadequately Controlled By Latanoprost
Status: Enrolling
Updated: 7/22/2013
Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
Updated: 7/22/2013
A Pilot, Single-Masked Study to Compare the Safety and Efficacy of ALZ-1101 (Latanoprost 0.005%/Dorzolamide 2.0%) to Latanoprost Ophthalmic Solution, 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension With Intraocular Pressure Inadequately Controlled By Latanoprost
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
Updated: 7/22/2013
A Pilot, Single-Masked Study to Compare the Safety and Efficacy of ALZ-1101 (Latanoprost 0.005%/Dorzolamide 2.0%) to Latanoprost Ophthalmic Solution, 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension With Intraocular Pressure Inadequately Controlled By Latanoprost
Status: Enrolling
Updated: 7/22/2013
Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
Updated: 7/22/2013
A Pilot, Single-Masked Study to Compare the Safety and Efficacy of ALZ-1101 (Latanoprost 0.005%/Dorzolamide 2.0%) to Latanoprost Ophthalmic Solution, 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension With Intraocular Pressure Inadequately Controlled By Latanoprost
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
Updated: 7/22/2013
A Pilot, Single-Masked Study to Compare the Safety and Efficacy of ALZ-1101 (Latanoprost 0.005%/Dorzolamide 2.0%) to Latanoprost Ophthalmic Solution, 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension With Intraocular Pressure Inadequately Controlled By Latanoprost
Status: Enrolling
Updated: 7/22/2013
Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
Updated: 7/22/2013
A Pilot, Single-Masked Study to Compare the Safety and Efficacy of ALZ-1101 (Latanoprost 0.005%/Dorzolamide 2.0%) to Latanoprost Ophthalmic Solution, 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension With Intraocular Pressure Inadequately Controlled By Latanoprost
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
Updated: 7/22/2013
A Pilot, Single-Masked Study to Compare the Safety and Efficacy of ALZ-1101 (Latanoprost 0.005%/Dorzolamide 2.0%) to Latanoprost Ophthalmic Solution, 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension With Intraocular Pressure Inadequately Controlled By Latanoprost
Status: Enrolling
Updated: 7/22/2013
Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
Updated: 7/22/2013
A Pilot, Single-Masked Study to Compare the Safety and Efficacy of ALZ-1101 (Latanoprost 0.005%/Dorzolamide 2.0%) to Latanoprost Ophthalmic Solution, 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension With Intraocular Pressure Inadequately Controlled By Latanoprost
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema
Updated: 8/1/2013
A Phase I/II Study Comparing the Treatment of Clinically Significant Diabetic Macular Edema (CSDME) With 0.5mg Ranibizumab, 1.0mg Ranibizumab and 2.0mg Ranibizumab
Status: Enrolling
Updated: 8/1/2013
Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema
Updated: 8/1/2013
A Phase I/II Study Comparing the Treatment of Clinically Significant Diabetic Macular Edema (CSDME) With 0.5mg Ranibizumab, 1.0mg Ranibizumab and 2.0mg Ranibizumab
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema
Updated: 8/1/2013
A Phase I/II Study Comparing the Treatment of Clinically Significant Diabetic Macular Edema (CSDME) With 0.5mg Ranibizumab, 1.0mg Ranibizumab and 2.0mg Ranibizumab
Status: Enrolling
Updated: 8/1/2013
Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema
Updated: 8/1/2013
A Phase I/II Study Comparing the Treatment of Clinically Significant Diabetic Macular Edema (CSDME) With 0.5mg Ranibizumab, 1.0mg Ranibizumab and 2.0mg Ranibizumab
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects
Updated: 8/6/2013
A Study of the Effects of a Single Osteopathic Manipulative Treatment (OMT) on Intraocular Pressure (IOP)in Un-medicated Confirmed Ocular Hypertensive (OHT) or Glaucoma Suspect Subjects
Status: Enrolling
Updated: 8/6/2013
Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects
Updated: 8/6/2013
A Study of the Effects of a Single Osteopathic Manipulative Treatment (OMT) on Intraocular Pressure (IOP)in Un-medicated Confirmed Ocular Hypertensive (OHT) or Glaucoma Suspect Subjects
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
Omega 3 Supplementation and Ocular Surface Disease in Glaucoma
Updated: 8/7/2013
Omega-3 Fatty Acid Nutritional Supplementation in the Treatment of Ocular Surface Disease Associated With Intraocular Pressure-Lowering Medications
Status: Enrolling
Updated: 8/7/2013
Omega 3 Supplementation and Ocular Surface Disease in Glaucoma
Updated: 8/7/2013
Omega-3 Fatty Acid Nutritional Supplementation in the Treatment of Ocular Surface Disease Associated With Intraocular Pressure-Lowering Medications
Status: Enrolling
Updated: 8/7/2013
Click here to add this to my saved trials
Study of FTY720 in Patients With Uveitis
Updated: 8/9/2013
A Multicenter, Randomized, Active-controlled Study to Assess the Safety, Tolerability, and Efficacy of FTY720 in Patients With Acute, Noninfectious Intermediate, Posterior and Pan Uveitis
Status: Enrolling
Updated: 8/9/2013
Study of FTY720 in Patients With Uveitis
Updated: 8/9/2013
A Multicenter, Randomized, Active-controlled Study to Assess the Safety, Tolerability, and Efficacy of FTY720 in Patients With Acute, Noninfectious Intermediate, Posterior and Pan Uveitis
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Evaluation of OCT Measurements
Updated: 8/12/2013
Evaluation of the Precision and Accuracy of OCT Measurements in Retinal and Glaucoma Patients
Status: Enrolling
Updated: 8/12/2013
Evaluation of OCT Measurements
Updated: 8/12/2013
Evaluation of the Precision and Accuracy of OCT Measurements in Retinal and Glaucoma Patients
Status: Enrolling
Updated: 8/12/2013
Click here to add this to my saved trials
Evaluation of OCT Measurements
Updated: 8/12/2013
Evaluation of the Precision and Accuracy of OCT Measurements in Retinal and Glaucoma Patients
Status: Enrolling
Updated: 8/12/2013
Evaluation of OCT Measurements
Updated: 8/12/2013
Evaluation of the Precision and Accuracy of OCT Measurements in Retinal and Glaucoma Patients
Status: Enrolling
Updated: 8/12/2013
Click here to add this to my saved trials
Evaluation of OCT Measurements
Updated: 8/12/2013
Evaluation of the Precision and Accuracy of OCT Measurements in Retinal and Glaucoma Patients
Status: Enrolling
Updated: 8/12/2013
Evaluation of OCT Measurements
Updated: 8/12/2013
Evaluation of the Precision and Accuracy of OCT Measurements in Retinal and Glaucoma Patients
Status: Enrolling
Updated: 8/12/2013
Click here to add this to my saved trials
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Updated: 8/23/2013
The Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery.
Status: Enrolling
Updated: 8/23/2013
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Updated: 8/23/2013
The Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery.
Status: Enrolling
Updated: 8/23/2013
Click here to add this to my saved trials
Comparing Visual Acuity Measurements (How Well You Can See) Using a Standard ETDRS Chart & a Handheld ETDRS Chart
Updated: 8/26/2013
Prospective Determination of Agreement Between Standard ETDRS (Early Treatment Diabetic Retinopathy Study) Chart and Handheld Illuminated ETDRS Equivalent Chart in Eyes With Retinal Pathology
Status: Enrolling
Updated: 8/26/2013
Comparing Visual Acuity Measurements (How Well You Can See) Using a Standard ETDRS Chart & a Handheld ETDRS Chart
Updated: 8/26/2013
Prospective Determination of Agreement Between Standard ETDRS (Early Treatment Diabetic Retinopathy Study) Chart and Handheld Illuminated ETDRS Equivalent Chart in Eyes With Retinal Pathology
Status: Enrolling
Updated: 8/26/2013
Click here to add this to my saved trials
Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration
Updated: 8/26/2013
A Phase 1 Randomized, Double-masked, Vehicle-controlled, Dose Escalation Study of the Ocular Safety and Tolerability of MC-1101 in Medically Stable Individuals
Status: Enrolling
Updated: 8/26/2013
Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration
Updated: 8/26/2013
A Phase 1 Randomized, Double-masked, Vehicle-controlled, Dose Escalation Study of the Ocular Safety and Tolerability of MC-1101 in Medically Stable Individuals
Status: Enrolling
Updated: 8/26/2013
Click here to add this to my saved trials
Functional Vision in TBI
Updated: 8/29/2013
Functional Vision Consequences of Rehabilitation for TBI Vision Loss
Status: Enrolling
Updated: 8/29/2013
Functional Vision in TBI
Updated: 8/29/2013
Functional Vision Consequences of Rehabilitation for TBI Vision Loss
Status: Enrolling
Updated: 8/29/2013
Click here to add this to my saved trials
Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems
Updated: 8/29/2013
Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems
Status: Enrolling
Updated: 8/29/2013
Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems
Updated: 8/29/2013
Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems
Status: Enrolling
Updated: 8/29/2013
Click here to add this to my saved trials
Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging
Updated: 9/23/2013
Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in the Imaging of Retinovascular Disease
Status: Enrolling
Updated: 9/23/2013
Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging
Updated: 9/23/2013
Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in the Imaging of Retinovascular Disease
Status: Enrolling
Updated: 9/23/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Updated: 9/26/2013
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Telemedicine Approaches to Evaluating Acute-phase ROP
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
Click here to add this to my saved trials
Telemedicine Approaches to Evaluating Acute-phase ROP
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
Click here to add this to my saved trials
Telemedicine Approaches to Evaluating Acute-phase ROP
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
Click here to add this to my saved trials
Telemedicine Approaches to Evaluating Acute-phase ROP
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
Click here to add this to my saved trials
Telemedicine Approaches to Evaluating Acute-phase ROP
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Updated: 9/27/2013
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
Click here to add this to my saved trials